Insider Trading History of Soteropoulos Paula


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Soteropoulos Paula since year 2005. The trader's CIK number is 1692444. At the time of the last reporting, Soteropoulos Paula was the Chief Executive Officer of Akcea Therapeutics, Inc. . (stock ticker symbol AKCA). See this page for all insider trading activities at Akcea Therapeutics, Inc. .

Note that in the past Soteropoulos Paula also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Soteropoulos Paula since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-04-08 AKCA Akcea Therapeutics, Inc. Option Ex 1,787 6.48 11,579
2019-04-05 AKCA Akcea Therapeutics, Inc. Sale 30,000 32.11 963,300
2019-04-05 AKCA Akcea Therapeutics, Inc. Option Ex 30,000 6.48 194,400
2019-04-08 AKCA Akcea Therapeutics, Inc. Sale 1,787 32.17 57,480
2019-03-06 AKCA Akcea Therapeutics, Inc. Sale 18,386 32.14 590,852
2019-03-06 AKCA Akcea Therapeutics, Inc. Option Ex 18,386 6.48 119,141
2019-01-28 QURE Uniqure N.v. Sale 1,210 31.32 37,897
2018-01-29 QURE Uniqure N.v. Sale 2,878 18.53 53,329

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soteropoulos Paula (Chief Executive Officer of Akcea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.